Clinical Trials
6
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)β’ Click on a phase to view related trials
Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease
- Conditions
- Alcoholic HepatitisAlcohol-related Liver Disease
- First Posted Date
- 2025-07-11
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- HepQuant, LLC
- Target Recruit Count
- 40
- Registration Number
- NCT07060547
- Locations
- πΊπΈ
Stanford University Dept. of Medicine -Gastroenterology & Hepatology, Redwood City, California, United States
Cholate Clearance in Fontan and Heart Failure
- Conditions
- FontanRight Heart Failure
- First Posted Date
- 2025-06-06
- Last Posted Date
- 2025-07-15
- Lead Sponsor
- HepQuant, LLC
- Target Recruit Count
- 75
- Registration Number
- NCT07009132
- Locations
- πΊπΈ
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
The SHUNT-V Study for Varices
- Conditions
- Chronic Liver Disease
- First Posted Date
- 2018-07-12
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- HepQuant, LLC
- Target Recruit Count
- 306
- Registration Number
- NCT03583996
- Locations
- πΊπΈ
Arizona Liver Health, Chandler, Arizona, United States
πΊπΈSouthern CA Research Center, Coronado, California, United States
πΊπΈCalifornia Liver Research Institute, Pasadena, California, United States
The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology
- Conditions
- NASH - Nonalcoholic Steatohepatitis
- First Posted Date
- 2017-09-27
- Last Posted Date
- 2021-08-09
- Lead Sponsor
- HepQuant, LLC
- Target Recruit Count
- 17
- Registration Number
- NCT03294941
- Locations
- πΊπΈ
Schiff Center for Liver Diseases, Miami, Florida, United States
πΊπΈUniversity of PA, Philadelphia, Pennsylvania, United States
πΊπΈMethodist Dallas Medical Center, Dallas, Texas, United States
Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124
- Conditions
- Severe Alcoholic Hepatitis
- Interventions
- First Posted Date
- 2017-03-23
- Last Posted Date
- 2021-08-30
- Lead Sponsor
- HepQuant, LLC
- Registration Number
- NCT03087968
- Locations
- πΊπΈ
Southern California Research Center, Coronado, California, United States
πΊπΈUniversity of Miami, Miami, Florida, United States
πΊπΈEmory University, Atlanta, Georgia, United States
- Prev
- 1
- 2
- Next